CNCEC(SH:601117) Xin Lang Cai Jing·2025-12-22 01:27Core Viewpoint - China National Chemical Engineering Co., Ltd. (China Chemical) has shown mixed financial performance with a slight increase in revenue and profit, while its financing activities indicate a low level of investor confidence as reflected in the financing balance and stockholder changes [1][2][3]. Financing Summary - On December 19, China Chemical's financing buy-in amounted to 22.93 million yuan, while financing repayment was 35.66 million yuan, resulting in a net financing outflow of 12.73 million yuan [1]. - The total financing and securities balance for China Chemical reached 1.748 billion yuan, which is 3.73% of its market capitalization, indicating a low financing balance compared to the past year [1]. - The company had a high securities lending balance with 120,300 shares remaining, valued at 926,300 yuan, which is above the 60th percentile of the past year [1]. Financial Performance Summary - As of September 30, China Chemical reported a total of 1.35845 billion yuan in revenue for the first nine months of 2025, reflecting a year-on-year growth of 1.26% [2]. - The net profit attributable to shareholders for the same period was 4.232 billion yuan, showing a year-on-year increase of 10.28% [2]. Shareholder and Dividend Information - Since its A-share listing, China Chemical has distributed a total of 9.958 billion yuan in dividends, with 3.305 billion yuan paid out in the last three years [3]. - As of September 30, 2025, the number of shareholders increased to 111,200, up by 19.23%, while the average number of circulating shares per person decreased by 15.74% to 54,562 shares [2][3]. - The second-largest circulating shareholder, Hong Kong Central Clearing Limited, reduced its holdings by 11.2 million shares to 182 million shares [3].